Animals are used to test both the safety and efficacy of therapeutic drugs, cosmetics, household products, and chemicals. Fortunately there are developing numbers of effective non-animal alternatives that can replace the use of animals in pyrogen testing. Moreover, many countries have regulatory requirements that stipulate a ban on animal based pyrogen testing. There have been major changes in the European Union in recent years. In the EU the use of animals for pyrogen testing of cosmetic products has been banned since 2009, the use of animals for the testing of cosmetic ingredients also has been banned since March 2013. Furthermore, the EU banned the sale of any cosmetics tested on animals from March 2013 onwards. Israel imposed similar cosmetic testing bans in 2007 and 2013, and similar policy change is under consideration in India and South Korea. These factors are anticipated to present a lucrative growth opportunity for the global monocyte activation test market in the coming years.
The Monocyte Activation Test Market is segmented on the basis of Product, Source, End Users and region.
Major Product of Monocyte Activation Test Market covered are:
- Monocyte Activation Test Kits
- Reagents
Major Source of Monocyte Activation Test Market covered are:
- Blood Based
- Peripheral Blood Mononuclear Cell (PBMC) Based
- Cell Line Based
Major Applications of Monocyte Activation Test Market covered are:
- Medical Devices
- Lipid Parenteral
- Dialysis Liquids
- Blood Products
- Toxic/immune-modulatory Drugs
Rising prevalence and incidences of several diseases worldwide has triggered the need for advanced R&D scenario across all sectors of biotechnology, pharmaceuticals and research establishments. Both public and private sectors are now focusing on new innovative techniques to obtain latest medical breakthroughs. According to studies, it was estimated that the total spending on R&D by mid-market biotechnology companies, witnessed an increment of approximately 18% between 2015 and 2016. Growing need to address several forms of ailments has been crucial in dictating the funding and R&D spending by government establishments as well as major market players and other research institutes. Increasing R&D investments and spending is anticipated to positively contribute to the growth of the global monocyte activation test market.
No comments:
Post a Comment